Table 1.
Study participants’ characteristics, interview time points, and observed changes in weight, BMI and blood glucose levels from baseline to follow‐up
| Participant number | Gender | Age,years | Type 2 diabetes duration, years | T1 | T2 | Weight at T1, kg | BMI at T1, kg/m2 | FPGat T1,mmol/l | Weight loss at T2, kg | % Weight loss at T2, kg | BMI change at T2, kg/m2 | FPG change at T2, mmol/l | % FPG change at T2, mmol/l |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1* | Man | 67 | 3.5 | X | X | 106 | 34.6 | 7.39 | –16.90 | –15.94 | –5.5 | –2.25 | –30.48 |
| 2 | Woman | 61 | 11 | X | X | 87.4 | 33.1 | 15.43 | –13.00 | –14.87 | –4.9 | –6.79 | –44.03 |
| 3† | Woman | 65 | 3 | X | X | 87.4 | 33.5 | 11.88 | –11.70 | –13.39 | –4.5 | –4.20 | –35.33 |
| 4* | Woman | 42 | 1 | X | 112.9 | 36.4 | 8.89 | –13.30 | –11.78 | –4.3 | –2.64 | –29.71 | |
| 5† | Man | 44 | 2.5 | X | X | 106.5 | 36.4 | 12.65 | –12.90 | –12.11 | –4.4 | –5.48 | –43.33 |
| 6* | Man | 54 | 0.5 | X | X | 90.9 | 32.4 | 6.70 | –16.30 | –17.93 | –5.8 | –1.50 | –22.35 |
| 7† | Man | 65 | 13 | X | X | 119.80 | 41.0 | 13.54 | –16.70 | –13.94 | –5.7 | –6.48 | –47.87 |
| 8 | Man | 64 | 9 | X | 90.00 | 29.4 | 11.99 | –8.30 | –9.22 | –2.7 | –3.91 | –32.59 | |
| 9* | Man | 49 | 9.5 | X | X | 97.5 | 31.8 | 14.21 | –16.70 | –17.13 | –5.5 | –9.16 | –64.45 |
| 10‡ | Man | 52 | 1 | X | 107.6 | 34.0 | 11.5 | ||||||
| 11* | Woman | 47 | 2.5 | X | X | 109.5 | 39.0 | 6.93 | –17.20 | –15.71 | –6.1 | –1.67 | –24.04 |
| 12* | Woman | 35 | 1.5 | X | 102.2 | 38.0 | 9.42 | –15.00 | –14.68 | –5.6 | –3.97 | –42.17 | |
| 13* | Man | 69 | 8.5 | X | X | 105.2 | 37.7 | 8.84 | –18.00 | –17.11 | –6.5 | –5.11 | –57.79 |
| 14* | Man | 59 | 10 | X | X§ | 96.2 | 32.9 | 6.92 | –15.20 | –15.80 | –5.2 | –1.98 | –28.57 |
| 15* | Man | 69 | 3.5 | X | X | 108.6 | 33.1 | 8.45 | –22.20 | –20.44 | –6.8 | –3.81 | –45.07 |
| 16 | Woman | 64 | 12 | X | 119.2 | 45.7 | 15.43 | –14.90 | –12.50 | –5.7 | 1.11 | 7.19 | |
| 17* | Woman | 70 | 15 | X | X | 74.3 | 31.5 | 12.54 | –8.80 | –11.84 | –3.7 | –5.71 | –45.49 |
| 18 | Man | 69 | 18 | X | 104.2 | 32.2 | 17.32 | –14.50 | –13.92 | –4.5 | –5.44 | –31.41 |
VLED, very‐low‐energy diet; FPG, fasting plasma glucose; T1, interview at the beginning of the VLED; T2, interview at the end of the weight loss phase (week 8).
Negative values represent a decrease.
*Participant achieved normal (≤6.9 mmol/l) FPG levels.
†Participant achieved near‐normal (ranging from 7.06 to 7.68 mmol/l) FPG levels.
‡Participant discontinued the Counterbalance study, and his data were not included in any further analyses.
§Interview recording was corrupt due to a technical failure.